Breaking News

Covance, Merck Finalize Strategic Pact


Covance has closed its transaction with Merck to provide genomics analysis services under a five-year contract valued at $145 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Covance has closed its transaction with Merck to provide genomics analysis services under a five-year contract valued at $145 million. Covance has acquired Merck’s gene expression lab in Seattle, WA, and as of August 17th, assumed control of the facility and took on Merck’s Seattle employees. Sign up today for Contracting & Outsourcing 2009! contractpharma.com/2009conference...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters